Diagnosis and management of peritoneal metastases from ovarian cancer
- PMID: 22888339
- PMCID: PMC3408715
- DOI: 10.1155/2012/541842
Diagnosis and management of peritoneal metastases from ovarian cancer
Abstract
The management and the outcome of peritoneal metastases or recurrence from epithelial ovarian cancer are presented. The biology and the diagnostic tools of EOC peritoneal metastasis with a comprehensive approach and the most recent literatures data are discussed. The definition and the role of surgery and chemotherapy are presented in order to focuse on the controversial points. Finally, the paper discusses the new data about the introduction of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced epithelial ovarian cancer.
References
-
- American Cancer Society. Cancer facts and figures. 2010, http://www.cancer.org/acs/
-
- Liu J, Matulonis UA. New advances in ovarian cancer. Oncology. 2010;24(8):691–698. - PubMed
-
- Horner MJ, Ries LAG, Krapcho M, et al. SEER Cancer Statistics Review 1975—2006. Bethesda, Md, USA: 2010. http://seer.cancer.gov/csr/1975_2006/
-
- Heintz AP, Odicino F, Maisonneuve P. Carcinoma of the ovary FIGO 6th annual report on the results of treatment in Gynecological cancer. International Journal of Gynecology & Obstetrics. 2006;(supplement I):161–192. - PubMed
-
- Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer Journal for Clinicians. 2009;59(4):225–249. - PubMed
LinkOut - more resources
Full Text Sources
